Eligibility for vericiguat in a real-world heart failure population according to trial, guideline and label criteria: Data from the Swedish Heart Failure Registry

MLA

Nguyen, Ngoc V., et al. Eligibility for Vericiguat in a Real-World Heart Failure Population According to Trial, Guideline and Label Criteria: Data from the Swedish Heart Failure Registry. 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1428022672&authtype=sso&custid=ns315887.

APA

Nguyen, N. V., Lindberg, F., Benson, L., Ferrannini, G., Imbalzano, E., Mol, P. G. M., Dahlström, U., Rosano, G. M. C., Ezekowitz, J., Butler, J., Lund, L. H., & Savarese, G. (2023). Eligibility for vericiguat in a real-world heart failure population according to trial, guideline and label criteria: Data from the Swedish Heart Failure Registry.

Chicago

Nguyen, Ngoc V., Felix Lindberg, Lina Benson, Giulia Ferrannini, Egidio Imbalzano, Peter G. M. Mol, Ulf Dahlström, et al. 2023. “Eligibility for Vericiguat in a Real-World Heart Failure Population According to Trial, Guideline and Label Criteria: Data from the Swedish Heart Failure Registry.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1428022672&authtype=sso&custid=ns315887.